Similar articles

• Prazosin: a review of its pharmacological properties and therapeutic efficacy in hypertension.

  Brogden RN, Heel RC, Speight TM, Avery GS. Brogden RN, et al. Drugs. 1977 Sep;14(3):163-97. doi: 10.2165/00003495-197714030-00002. Drugs. 1977. PMID: 143363 Review. No abstract available.
• Prazosin in hypertension: a double-blind evaluation with methyldopa and placebo.

  Mroczek WJ, Fotiu S, Davidov ME, Finnerty FA Jr. Mroczek WJ, et al. Curr Ther Res Clin Exp. 1974 Aug;16(8):769-77. Curr Ther Res Clin Exp. 1974. PMID: 4217243 Clinical Trial. No abstract available.
• Double-blind studies of the clinical effectiveness of prazosin.

  Schnaper HW, Oberman A. Schnaper HW, et al. Postgrad Med. 1975 Nov;Spec No:81-7. Postgrad Med. 1975. PMID: 1105489 Clinical Trial.
• Prazosin in the treatment of hypertension.

  Adriaensen H, Vryens R. Adriaensen H, et al. Practitioner. 1975 Feb;214(1280):268-73. Practitioner. 1975. PMID: 1096120 Clinical Trial.
• Overview of clinical trials with urapidil.

  Schook CE, Radtke H, Wurst W, Thieme G. Schook CE, et al. Am J Cardiol. 1989 Aug 15;64(7):30D-37D. doi: 10.1016/0002-9149(89)90693-0. Am J Cardiol. 1989. PMID: 2667312 Review.